Progressive Care Inc. Garners Coverage in International Business
Times
MIAMI, FL -- April 11, 2019 -- InvestorsHub NewsWire
-- Progressive Care Inc. (OTCQB: RXMD), a personalized
healthcare services and technology company, today announced that it
has garnered media coverage in International Business
Times in an op-ed written by S. Parikh Mars, CEO of
Progressive Care Inc. titled, Opioid Epidemic: 21st
Century Thinking Needed to Solve a 21st Century Problem.
“It is a true honor to have the opportunity to write about a
subject very close to my heart. Progressive Care is doing
everything in our power to address the opioid crisis,” said S.
Parikh Mars, CEO of Progressive Care Inc. “Progressive Care aims to
provide alternatives to opioids that suit each patient’s needs in
hopes to lower our patient's dependence on opioids and fight the
epidemic.”
In the opinion piece titled Opioid Epidemic: 21st Century
Thinking Needed To Solve A 21st Century
Problem, published April 8, 2019
in International Business Times, Mars discusses that
in order to address the opioid epidemic, we must first understand
it. Mars says, “ Many states have implemented drastic opioid
restrictions, manufacturers and pharmaceutical wholesale vendors
have limited supply, pain clinics have shut down and doctors
willing to prescribe opioids are fewer and further between. Yet,
the problem persists across large swaths of the country and the
number of people delivering innovative solutions is dwindling.
However, the battle is not lost. The solutions we seek may be right
under our noses.”
In the article Mars expressed “we need a new way of thinking
about pain to begin with. Currently, pain is evaluated on a 1-10
scale to determine severity and medication is prescribed to address
this subjective assessment. However, not all pain is created
equally, and no two people feel the same pain the same way.” She
concludes that “ To end this crisis, we need to use personalized
medicine and a more nuanced view of pain and its treatment. We need
to think of pain management in terms of effectiveness and not in
terms of strength, choosing non-addictive medicines to address
patient-specific pain before resorting to opioid therapies.”
Progressive Care has responded to the opioid epidemic by
providing patients with an alternative to opioids, a compound
lotion to suit each patient’s needs. The cream hits the target area
and helps to relieve pain quickly without having to interact with
other medications, and without affecting the liver, and kidney,
reducing the risk of addiction or death from taking opioids.
Progressive Care Inc.’s wholly owned subsidiary PharmCo, LLC is in the top 10% in the
nation evaluated by Humana Inc. and will
continue to provide top-of-line services to their patients to fight
the opioid epidemic.
The recent media coverage comes after the company’s efforts to
provide its network with more healthcare informational resources
through PharmCo Pharmacy. Additional
commentary from Progressive Care’s CEO about the company and
industry as a whole can be found on the Progressive Care blog and PharmCo blog.
For more immediate updates on the company’s media coverage,
connect with Progressive Care and PharmCo on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its
PharmCo, LLC, is a South Florida health services organization and
provider of prescription pharmaceuticals, compounded medications,
provider of tele-pharmacy services, the sale of anti-retroviral
medications, medication therapy management (MTM), the supply of
prescription medications to long-term care facilities, and health
practice risk management.
Cautionary Statement Regarding Forward-Looking
Statements
Statements contained herein that are not based upon current or
historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such forward-looking statements reflect the Company’s
expectations about its future operating results, performance, and
opportunities that involve substantial risks and uncertainties.
These statements include but are not limited to statements
regarding the intended terms of the offering, closing of the
offering and use of any proceeds from the offering. When used
herein, the words “anticipate,” “believe,” “estimate,” “upcoming,”
“plan,” “target,” “intend” and “expect” and similar expressions, as
they relate to Progressive Care Inc., its subsidiaries, or its
management, are intended to identify such forward-looking
statements. These forward-looking statements are based on
information currently available to the Company and are subject to a
number of risks, uncertainties, and other factors that could cause
the Company's actual results, performance, prospects, and
opportunities to differ materially from those expressed in, or
implied by, these forward-looking statements.
Public Relations Contact:
Kathleen Gonzales, CMW Media
kathleen@cmwmedia.com
www.cmwmedia.com
Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Sep 2023 to Sep 2024